Exact Mass: 271.1392336

Exact Mass Matches: 271.1392336

Found 79 metabolites which its exact mass value is equals to given mass value 271.1392336, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

2-(3-Carboxy-3-(methylammonio)propyl)-L-histidine

[3-[[4-(2-amino-2-Carboxy-ethyl)-1H-imidazol-2-yl]]-1-carboxy- propyl]-methyl-ammonium

C11H19N4O4 (271.1406234)


2-(3-Carboxy-3-(methylammonio)propyl)-L-histidine is an unusual amino acid that results from the post-translational modification of histidine in certain proteins. In particular, it is a post-translational derivative of histidine that exists in protein synthesis elongation factor 2 (EF2) at the site of diphtheria toxin-catalyzed ADP-ribosylation of elongation factor 2. It is a precursor for diphthamide. This compound is a substrate for the enzyme diphthine synthase (EC 2.1.1.98). This enzyme catalyzes the chemical reaction: S-adenosyl-L-methionine + 2-(3-carboxy-3-aminopropyl)-L-histidine = S-adenosyl-L-homocysteine + 2-[3-carboxy-3-(methylammonio)propyl]-L-histidine [HMDB] 2-(3-Carboxy-3-(methylammonio)propyl)-L-histidine is an unusual amino acid that results from the post-translational modification of histidine in certain proteins. In particular, it is a post-translational derivative of histidine that exists in protein synthesis elongation factor 2 (EF2) at the site of diphtheria toxin-catalyzed ADP-ribosylation of elongation factor 2. It is a precursor for diphthamide. This compound is a substrate for the enzyme diphthine synthase (EC 2.1.1.98). This enzyme catalyzes the chemical reaction: S-adenosyl-L-methionine + 2-(3-carboxy-3-aminopropyl)-L-histidine = S-adenosyl-L-homocysteine + 2-[3-carboxy-3-(methylammonio)propyl]-L-histidine.

   

Bupranolol

1-(tert-butylamino)-3-(2-chloro-5-methylphenoxy)propan-2-ol

C14H22ClNO2 (271.1338982)


Bupranolol is only found in individuals that have used or taken this drug. It is a non-selective beta blocker without intrinsic sympathomimetic activity (ISA), but with strong membrane stabilizing activity. Its potency is similar to propranolol:http://www.drugbank.ca/drugs/DB00571. Bupranolol competes with sympathomimetic neurotransmitters such as catecholamines for binding at beta(1)-adrenergic receptors in the heart, inhibiting sympathetic stimulation. This results in a reduction in resting heart rate, cardiac output, systolic and diastolic blood pressure, and reflex orthostatic hypotension. C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AA - Beta blocking agents, non-selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents Bupranolol is an orally active, competitive and non-selective β-adrenoceptor antagonist without intrinsic sympathomimetic activity[1].

   

1-Tert-Butyl 4-ethyl 3-oxopiperidine-1,4-dicarboxylate

1-Tert-butyl 4-ethyl 3-oxopiperidine-1,4-dicarboxylic acid

C13H21NO5 (271.1419656)


   

N-Benzyl-D-glucamine

6-(benzylamino)hexane-1,2,3,4,5-pentol

C13H21NO5 (271.1419656)


   

(R)-N-(Quinuclidin-3-yl)furo(2,3-C)pyridine-5-carboxamide

N-{1-azabicyclo[2.2.2]octan-3-yl}furo[2,3-c]pyridine-5-carboxamide

C15H17N3O2 (271.1320702)


   

Quinocitrinine A

(+)-2,3-Dihydro-6-hydroxy-4-methyl-3-(1-methylpropyl)-1-oxo-1H-pyrrolo[3,4-b]quinolinium

C16H19N2O2 (271.1446454)


   

Quinocitrinine B

(-)-2,3-Dihydro-6-hydroxy-4-methyl-3-(1-methylpropyl)-1-oxo-1H-pyrrolo[3,4-b]quinolinium

C16H19N2O2 (271.1446454)


   
   
   
   

2-(tert-Butylsulfonyl)-3-(piperidinoamino)acrylonitrile

2-(tert-Butylsulfonyl)-3-(piperidinoamino)acrylonitrile

C12H21N3O2S (271.13544060000004)


   
   

N1-Demethylcynometrine

N1-Demethylcynometrine

C15H17N3O2 (271.1320702)


   

3-indol-3-ylmethyl-1,6-dimethyl-piperazine-2,5-dione|cyclo(L-Trp-N-methyl-L-Ala-)

3-indol-3-ylmethyl-1,6-dimethyl-piperazine-2,5-dione|cyclo(L-Trp-N-methyl-L-Ala-)

C15H17N3O2 (271.1320702)


   
   

1,N6-4-Oxo-(2E)-nonenal-adenine

1,N6-4-Oxo-(2E)-nonenal-adenine

C14H17N5O1 (271.1433032)


   

Pesticide5_Methoprotryne_C11H21N5OS_

Pesticide5_Methoprotryne_C11H21N5OS_

C11H21N5OS (271.14667360000004)


   

Bupranolol

tert-butyl[3-(2-chloro-5-methylphenoxy)-2-hydroxypropyl]amine

C14H22ClNO2 (271.1338982)


C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AA - Beta blocking agents, non-selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents Bupranolol is an orally active, competitive and non-selective β-adrenoceptor antagonist without intrinsic sympathomimetic activity[1].

   

6-nitro-2-(piperidin-1-ylmethyl)quinoline

6-nitro-2-(piperidin-1-ylmethyl)quinoline

C15H17N3O2 (271.1320702)


   

BIS(2-CYANOETHYL) DIISOPROPYLPHOSPHORAMIDITE

BIS(2-CYANOETHYL) DIISOPROPYLPHOSPHORAMIDITE

C12H22N3O2P (271.1449562)


Bis(2-cyanoethyl) diisopropylphosphoramidite is a phosphorite monomer that can be used in the synthesis of oligonucleotides.

   

ProcainaMide hydrochloride

ProcainaMide hydrochloride

C13H22ClN3O (271.1451312)


D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

N-[(3,4-dimethoxyphenyl)methyl]cyclopentanamine,hydrochloride

N-[(3,4-dimethoxyphenyl)methyl]cyclopentanamine,hydrochloride

C14H22ClNO2 (271.1338982)


   

N-Boc-3-carboethoxy-4-piperidone

N-Boc-3-carboethoxy-4-piperidone

C13H21NO5 (271.1419656)


   

4-(4-Fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridin-2(1H)-one

4-(4-Fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridin-2(1H)-one

C17H18FNO (271.13723500000003)


   

methyl 4-piperidin-1-ylquinazoline-6-carboxylate

methyl 4-piperidin-1-ylquinazoline-6-carboxylate

C15H17N3O2 (271.1320702)


   

5-[cyclopentyl(prop-2-enyl)amino]-2-nitrobenzonitrile

5-[cyclopentyl(prop-2-enyl)amino]-2-nitrobenzonitrile

C15H17N3O2 (271.1320702)


   

1-isopropyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride

1-isopropyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride

C14H22ClNO2 (271.1338982)


   

6,7-DIETHOXY-1-METHYL-1,2,3,4-TETRAHYDROISOQUINOLINE HYDROCHLORIDE

6,7-DIETHOXY-1-METHYL-1,2,3,4-TETRAHYDROISOQUINOLINE HYDROCHLORIDE

C14H22ClNO2 (271.1338982)


   

(R)-1-TERT-BUTYL 2-ETHYL 5-OXOPIPERIDINE-1,2-DICARBOXYLATE

(R)-1-TERT-BUTYL 2-ETHYL 5-OXOPIPERIDINE-1,2-DICARBOXYLATE

C13H21NO5 (271.1419656)


   

5-(1H-imidazol-1-yl)pyridine-3-boronic acid pinacol ester

5-(1H-imidazol-1-yl)pyridine-3-boronic acid pinacol ester

C14H18BN3O2 (271.1491998)


   

(S)-1-TERT-BUTYL 2-ETHYL 5-OXOPIPERIDINE-1,2-DICARBOXYLATE

(S)-1-TERT-BUTYL 2-ETHYL 5-OXOPIPERIDINE-1,2-DICARBOXYLATE

C13H21NO5 (271.1419656)


   

2-[4-(1-piperidinyl)-6-quinazolinyl]acetic acid

2-[4-(1-piperidinyl)-6-quinazolinyl]acetic acid

C15H17N3O2 (271.1320702)


   

5,6,8,9-Tetrahydro-7H-dibenzo[c,g]carbazole

5,6,8,9-Tetrahydro-7H-dibenzo[c,g]carbazole

C20H17N (271.1360922)


   

2-(1H-PYRAZOL-1-YL)-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE

2-(1H-PYRAZOL-1-YL)-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE

C14H18BN3O2 (271.1491998)


   

tert-butyl 3-(3-ethoxy-3-oxopropanoyl)azetidine-1-carboxylate

tert-butyl 3-(3-ethoxy-3-oxopropanoyl)azetidine-1-carboxylate

C13H21NO5 (271.1419656)


   

CIS-1,2,3-TRIPHENYLAZIRIDINE

CIS-1,2,3-TRIPHENYLAZIRIDINE

C20H17N (271.1360922)


   

(R)-3-AMINO-4-(4-(TERT-BUTYL)PHENYL)BUTANOIC ACID HYDROCHLORIDE

(R)-3-AMINO-4-(4-(TERT-BUTYL)PHENYL)BUTANOIC ACID HYDROCHLORIDE

C14H22ClNO2 (271.1338982)


   

1-Methyl-4-(4-nitro-1-naphthyl)piperazine

1-Methyl-4-(4-nitro-1-naphthyl)piperazine

C15H17N3O2 (271.1320702)


   

5,6-Dihydroxy-N-methyl-N-propyl-aminotetraline hydrochloride

5,6-Dihydroxy-N-methyl-N-propyl-aminotetraline hydrochloride

C14H22ClNO2 (271.1338982)


   

4-ethenyl-N,N-diphenylaniline

4-ethenyl-N,N-diphenylaniline

C20H17N (271.1360922)


   

N-Benzyl-D-GlucamineN-Benzyl-D-Glucamine

N-Benzyl-D-GlucamineN-Benzyl-D-Glucamine

C13H21NO5 (271.1419656)


   

3-Phenylisoxazole-5-Boronic Acid pinacol ester

3-Phenylisoxazole-5-Boronic Acid pinacol ester

C15H18BNO3 (271.1379668)


   

n-(4-phenylbenzylidene)benzylamine

n-(4-phenylbenzylidene)benzylamine

C20H17N (271.1360922)


   

1-TERT-BUTYL 2-ETHYL 3-OXOPIPERIDINE-1,2-DICARBOXYLATE

1-TERT-BUTYL 2-ETHYL 3-OXOPIPERIDINE-1,2-DICARBOXYLATE

C13H21NO5 (271.1419656)


   

4-[(2-methoxyphenyl)azo]-5-methyl-o-anisidine

4-[(2-methoxyphenyl)azo]-5-methyl-o-anisidine

C15H17N3O2 (271.1320702)


   

2-[4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-oxazole

2-[4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-oxazole

C15H18BNO3 (271.1379668)


   

N-(4-FLUOROBENZOYLMETHYL)-N-ISOPROPYLANILINE

N-(4-FLUOROBENZOYLMETHYL)-N-ISOPROPYLANILINE

C17H18FNO (271.13723500000003)


   

2-Methyl-2-propanyl 3-hydroxy-1-oxo-2-oxa-6-azaspiro[4.5]decane-6 -carboxylate

2-Methyl-2-propanyl 3-hydroxy-1-oxo-2-oxa-6-azaspiro[4.5]decane-6 -carboxylate

C13H21NO5 (271.1419656)


   

Methyl 3-(methoxycarbonyl)-7-oxo-9-azabicyclo[3.3.1]nonane-9-acetate

Methyl 3-(methoxycarbonyl)-7-oxo-9-azabicyclo[3.3.1]nonane-9-acetate

C13H21NO5 (271.1419656)


   

benzyl-[2-(3-methoxyanilino)-2-oxoethyl]azanium

benzyl-[2-(3-methoxyanilino)-2-oxoethyl]azanium

C16H19N2O2+ (271.1446454)


   

ETHYL 5-BENZYL-1,4,5,6-TETRAHYDROPYRROLO[3,4-C]PYRAZOLE-3-CARBOXYLATE

ETHYL 5-BENZYL-1,4,5,6-TETRAHYDROPYRROLO[3,4-C]PYRAZOLE-3-CARBOXYLATE

C15H17N3O2 (271.1320702)


   

3-AMINO-1,4-DIMETHYL-5H-PYRIDO[4,3-B]INDOLE, ACETATE

3-AMINO-1,4-DIMETHYL-5H-PYRIDO[4,3-B]INDOLE, ACETATE

C15H17N3O2 (271.1320702)


   

Benzenemethanamine, N- (diphenylmethylene)-

Benzenemethanamine, N- (diphenylmethylene)-

C20H17N (271.1360922)


   

L-Homophenylalanine tert-Butyl Ester Hydrochloride

L-Homophenylalanine tert-Butyl Ester Hydrochloride

C14H22ClNO2 (271.1338982)


   

3-Amino-4-ethyl-5H-pyrido(4,3-b)indole acetate

3-Amino-4-ethyl-5H-pyrido(4,3-b)indole acetate

C15H17N3O2 (271.1320702)


   

N-cyclopentyl-5-(4-fluorophenyl)-2-methylpyrimidin-4-amine

N-cyclopentyl-5-(4-fluorophenyl)-2-methylpyrimidin-4-amine

C16H18FN3 (271.14846800000004)


   

N-Methyl-N-(3-chloropropyl)-3,4-dimethoxyphenethylamine

N-Methyl-N-(3-chloropropyl)-3,4-dimethoxyphenethylamine

C14H22ClNO2 (271.1338982)


   

(R)-tert-Butyl 3-amino-4-phenylbutanoate hydrochloride

(R)-tert-Butyl 3-amino-4-phenylbutanoate hydrochloride

C14H22ClNO2 (271.1338982)


   

Methyl 1-(Boc-amino)-4-oxo-cyclohexanecarboxylate

Methyl 1-(Boc-amino)-4-oxo-cyclohexanecarboxylate

C13H21NO5 (271.1419656)


   

2-(1H-PYRAZOL-1-YL)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE

2-(1H-PYRAZOL-1-YL)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE

C14H18BN3O2 (271.1491998)


   

(S)-3-AMINO-4-(4-(TERT-BUTYL)PHENYL)BUTANOIC ACID HYDROCHLORIDE

(S)-3-AMINO-4-(4-(TERT-BUTYL)PHENYL)BUTANOIC ACID HYDROCHLORIDE

C14H22ClNO2 (271.1338982)


   

Ethyl (R)-(+)-1-Boc-4-oxopiperidine-2-carboxylate

Ethyl (R)-(+)-1-Boc-4-oxopiperidine-2-carboxylate

C13H21NO5 (271.1419656)


   

2-[(4-Amino-3-methylphenyl)ethylamino]ethyl sulfate

2-[(4-Amino-3-methylphenyl)ethylamino]ethyl sulfate

C12H21N3O2S (271.13544060000004)


   

N-Methyl-N-(3-chloropropyl)-3,4-dimethoxy benzenethylamine

N-Methyl-N-(3-chloropropyl)-3,4-dimethoxy benzenethylamine

C14H22ClNO2 (271.1338982)


   

N-BENZYLIDENE-N-(DIPHENYLMETHYL)AMINE

N-BENZYLIDENE-N-(DIPHENYLMETHYL)AMINE

C20H17N (271.1360922)


   

Methyl 1-Boc-3-methyl-4-oxo-piperidine-3-carboxylate

Methyl 1-Boc-3-methyl-4-oxo-piperidine-3-carboxylate

C13H21NO5 (271.1419656)


   

O-(tert-Butyldiphenylsilyl)hydroxylamine

O-(tert-Butyldiphenylsilyl)hydroxylamine

C16H21NOSi (271.1392336)


   

Amylocaine hydrochloride

Amylocaine hydrochloride

C14H22ClNO2 (271.1338982)


C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

N-1-azabicyclo[2.2.2]oct-3-ylfuro[2,3-c]pyridine-5-carboxamide

N-1-azabicyclo[2.2.2]oct-3-ylfuro[2,3-c]pyridine-5-carboxamide

C15H17N3O2 (271.1320702)


   

Meprylcaine hydrochloride

Meprylcaine hydrochloride

C14H22ClNO2 (271.1338982)


C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide

N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide

C15H17N3O2 (271.1320702)


PHA-543613 is a potent, orally active, brain-penetrant and selective α7 nAChR agonist with a Ki of 8.8 nM. PHA-543613 displays selectivity for α7-nAChR over α3β4, α1β1γδ, α4β2 and 5-HT3 receptors[1]. PHA-543613 can be used for the cognitive deficits of Alzheimer's disease and schizophrenia research[2].

   

2-(3-Carboxy-3-(methylammonio)propyl)-L-histidine

[3-[[4-(2-amino-2-Carboxy-ethyl)-1H-imidazol-2-yl]]-1-carboxy- propyl]-methyl-ammonium

C11H19N4O4+ (271.1406234)


2-(3-Carboxy-3-(methylammonio)propyl)-L-histidine is an unusual amino acid that results from the post-translational modification of histidine in certain proteins. In particular, it is a post-translational derivative of histidine that exists in protein synthesis elongation factor 2 (EF2) at the site of diphtheria toxin-catalyzed ADP-ribosylation of elongation factor 2. It is a precursor for diphthamide. This compound is a substrate for the enzyme diphthine synthase (EC 2.1.1.98). This enzyme catalyzes the chemical reaction: S-adenosyl-L-methionine + 2-(3-carboxy-3-aminopropyl)-L-histidine = S-adenosyl-L-homocysteine + 2-[3-carboxy-3-(methylammonio)propyl]-L-histidine [HMDB] 2-(3-Carboxy-3-(methylammonio)propyl)-L-histidine is an unusual amino acid that results from the post-translational modification of histidine in certain proteins. In particular, it is a post-translational derivative of histidine that exists in protein synthesis elongation factor 2 (EF2) at the site of diphtheria toxin-catalyzed ADP-ribosylation of elongation factor 2. It is a precursor for diphthamide. This compound is a substrate for the enzyme diphthine synthase (EC 2.1.1.98). This enzyme catalyzes the chemical reaction: S-adenosyl-L-methionine + 2-(3-carboxy-3-aminopropyl)-L-histidine = S-adenosyl-L-homocysteine + 2-[3-carboxy-3-(methylammonio)propyl]-L-histidine.

   

Pronestyl

Pronestyl

C13H22ClN3O (271.1451312)


D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D049990 - Membrane Transport Modulators

   

L-glutamine 2-naphthylamide

L-glutamine 2-naphthylamide

C15H17N3O2 (271.1320702)


   

5-(3,5-Dimethyl-1-piperidinyl)-2-(2-furanyl)-4-oxazolecarbonitrile

5-(3,5-Dimethyl-1-piperidinyl)-2-(2-furanyl)-4-oxazolecarbonitrile

C15H17N3O2 (271.1320702)


   

5-nitro-N-[(4-propan-2-ylphenyl)methyl]-2-pyridinamine

5-nitro-N-[(4-propan-2-ylphenyl)methyl]-2-pyridinamine

C15H17N3O2 (271.1320702)


   

3,4,4a,5-Tetrahydrobenzo[g]isoquinolin-10(2H)-one, TMS derivative

3,4,4a,5-Tetrahydrobenzo[g]isoquinolin-10(2H)-one, TMS derivative

C16H21NOSi (271.1392336)


   

2-[3-Carboxy-3-(methylammonio)propyl]-L-histidine

2-[3-Carboxy-3-(methylammonio)propyl]-L-histidine

C11H19N4O4+ (271.1406234)


An ammonium ion that is a derivative of L-histidine having a 3-carboxy-3-(methylammonio)propyl group at the 2-position on the imidazole ring.